Capital Fund Management (CFM)
CLB icon

Capital Fund Management (CFM)’s Core Laboratories CLB Stock Holding History

Capital Fund Management (CFM)’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-80,200
Closed -$3.74M – 1847
2019
Q3 		$3.74M Sell
80,200
-73,700
-48% -$3.43M 0.03% 576
2019
Q2 		$8.05M Sell
153,900
-9,600
-6% -$563K 0.07% 366
2019
Q1 		$11.3M Buy
+163,500
New +$11M 0.1% 268
2018
Q3 		– Sell
-6,500
Closed -$820K – 1995
2018
Q2 		$820K Buy
+6,500
New +$791K ﹤0.01% 1404
2017
Q4 		– Sell
-2,100
Closed -$207K – 1806
2017
Q3 		$207K Buy
+2,100
New +$204K ﹤0.01% 1454
2017
Q1 		– Sell
-2,800
Closed -$336K – 1500
2016
Q4 		$336K Buy
+2,800
New +$310K ﹤0.01% 1402
2015
Q3 		– Sell
-3,800
Closed -$433K – 1441
2015
Q2 		$433K Sell
3,800
-1,900
-33% -$230K 0.01% 1131
2015
Q1 		$596K Buy
5,700
+3,500
+159% +$373K 0.01% 975
2014
Q4 		$265K Buy
+2,200
New +$289K ﹤0.01% 1392

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital Fund Management (CFM)'s CLB Position: Q4 2020 in Review

Capital Fund Management (CFM) sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 39,144 shares — an estimated $597K sold.

Capital Fund Management (CFM) first reported a position in CLB in Q2 2013 and held it in 17 quarters. The position peaked at $21.9M in Q2 2014. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Capital Fund Management (CFM) reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 39,144 Core Laboratories shares in Q4 2020, an estimated $597K.
  • Capital Fund Management (CFM) first reported a position in Core Laboratories in Q2 2013 and held it in 17 quarters.
  • Capital Fund Management (CFM)'s Core Laboratories position peaked at $21.9M in Q2 2014.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2020, filed 12 Feb 2021.